Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1012.15%
operating margin TTM
-871.25%
revenue TTM
10.15 Million
revenue per share TTM
0.11$
valuation ratios | |
|---|---|
| pe ratio | -0.43 |
| peg ratio | -0.04 |
| price to book ratio | -3.36 |
| price to sales ratio | 7.76 |
| enterprise value multiple | -0.90 |
| price fair value | -3.36 |
profitability ratios | |
|---|---|
| gross profit margin | 63.79% |
| operating profit margin | -871.25% |
| pretax profit margin | -1012.15% |
| net profit margin | -1012.15% |
| return on assets | -141.46% |
| return on equity | 549.95% |
| return on capital employed | -262.4% |
liquidity ratio | |
|---|---|
| current ratio | 1.76 |
| quick ratio | 1.68 |
| cash ratio | 1.60 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 328.10 |
| operating cycle | 331.82 |
| days of payables outstanding | 252.57 |
| cash conversion cycle | 79.25 |
| receivables turnover | 98.26 |
| payables turnover | 1.45 |
| inventory turnover | 1.11 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.85 |
| debt equity ratio | -4.66 |
| long term debt to capitalization | 1.47 |
| total debt to capitalization | 1.27 |
| interest coverage | -7.00 |
| cash flow to debt ratio | -1.33 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.18 |
| cash per share | 0.89 |
| operating cash flow per share | -1.18 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.33 |
| short term coverage ratios | -4.71 |
| capital expenditure coverage ratio | -2,256.56 |
Frequently Asked Questions
When was the last time Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) reported earnings?
Verrica Pharmaceuticals Inc. (VRCA) published its most recent earnings results on 05-11-2024.
What is Verrica Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Verrica Pharmaceuticals Inc. (NASDAQ:VRCA)'s trailing twelve months ROE is 549.95%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Verrica Pharmaceuticals Inc. (VRCA) currently has a ROA of -141.46%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VRCA's net profit margin stand at?
VRCA reported a profit margin of -1012.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VRCA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.76 in the most recent quarter. The quick ratio stood at 1.68, with a Debt/Eq ratio of -4.66.